Successful Long Term Antifungal Agent Therapy for Renal Candidiasis without Surgical Drainage in a Very Low Birth Weight Infant.
- Author:
Ji Hyun PARK
1
;
Im Jung CHOI
;
Sung Mi KIM
;
Jin Hwa JUNG
;
Gil Hyun KIM
Author Information
1. Department of Pediatrics, Maryknoll Hospital, Busan, Korea. ksm7090@hanmail.net
- Publication Type:Case Report
- Keywords:
Renal candidiasis;
Liposomal amphotericin B;
Fluconazole;
Prematurity
- MeSH:
Amphotericin B;
Candida;
Candida albicans;
Candidemia;
Candidiasis*;
Consensus;
Cross Infection;
Drainage*;
Fluconazole;
Humans;
Infant, Newborn;
Infant, Premature;
Infant, Very Low Birth Weight*;
Critical Care;
Kidney;
Mortality;
Sepsis;
Survival Rate
- From:Journal of the Korean Society of Neonatology
2004;11(1):81-86
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Improved survival rate of premature infants requiring intensive care lead into an increased risk for nosocomial infections such as disseminated fungal infection. Neonatal candida sepsis has become one of the most important causes of neonatal morbidity and mortality. The most common site of end organ involvement in premature infants with candidemia is the kidney. But no consensus has been reached concerning the treatment of candidemia in the newborn. We recently experienced a case of premature infant who was diagnosed as renal candidiasis with microabscess formation due to Candida Albicans and patient was treated successfully with long term liposomal amphotericin B and fluconazole therapy without surgical drainage.
